4//SEC Filing
Sarlis Nicholas J. 4
Accession 0000899243-19-008204
CIK 0001390478other
Filed
Mar 17, 8:00 PM ET
Accepted
Mar 18, 7:03 PM ET
Size
10.0 KB
Accession
0000899243-19-008204
Insider Transaction Report
Form 4
Sarlis Nicholas J.
Chief Medical Officer and SVP
Transactions
- Award
Stock Option (Right to Buy)
2019-03-14+50,000→ 50,000 totalExercise: $1.38Exp: 2019-12-31→ Common Stock (50,000 underlying)
Footnotes (1)
- [F1]All of the option shares will vest and become exercisable upon the closing of a Change of Control transaction (as defined in Mr. Sarlis' stock option grant notice), provided that the Reporting Person remains in continuous service with the Issuer on the vesting date.
Issuer
SELLAS Life Sciences Group, Inc.
CIK 0001390478
Entity typeother
Related Parties
1- filerCIK 0001724151
Filing Metadata
- Form type
- 4
- Filed
- Mar 17, 8:00 PM ET
- Accepted
- Mar 18, 7:03 PM ET
- Size
- 10.0 KB